NIH Cancels Study of Chelation as Autism Treatment - Wall Street Journal Blogs bi13750183 Stuff.co.nz NIH Cancels Study of Chelation as Autism Wall Street Journal Blogs, NY - 3 hours ago If some people are using a that most doctors think doesn?t work and may involve some real risks, should public health officials study the 'Unethical' autism research dropped The Press Association Study On Controversial Autism Called Off TopNews Health Buzz: Autism Study Halted and Other Health News U.S. News & World Report Discover Magazine - Reutersall 264 news articles..

Banks Loosen Up After Treatment - Forbes bi13750183 Banks Loosen Up After Forbes, NY - 4 hours ago LONDON - The logjam the money markets has eased--though only slightly--after the US Federal Reserve and a handful of the world's central banks announced ..

Wastewater treatment plan reports overflow - MLive.com bi13750183 Wastewater plan reports overflow MLive.com, MI - 4 hours ago The wastewater was partially treated before the discharge, but bacteria remains full . The results of tests for E. coli performed ..

Treatment starts on citrus plants after insect found - San Diego Union Tribune bi13750183 starts on citrus plants after insect found San Diego Union Tribune, United States - 6 hours ago By Leslie Berestein State agriculture department workers began pesticide yesterday of citrus plants on 16 properties infested a potentially State begins pesticide to halt insect San Jose Mercury News Asian Citrus Psyllid Ground Prevention Scheduled - San Imperial Valley News all 31 news articles..

Elekta Extends Line of Stereotactic Treatment Solutions at - MarketWatch bi13750183 Elekta Extends Line of Stereotactic Solutions at MarketWatch - 3 hours ago With new re-locatable frame and support for fractionated s, the Extend program now provides the ability to treat large or critically located Elekta: Interim Report May - July 2008/09 Business Wire (press release) all 21 news articles..

Thompson Cancer Survival Center to Take Cancer Program to the Next - Mark bi13750183 Thompson Cancer Survival Center to Take Cancer Program to the Next MarketWatch - 4 hours ago Chester Ramsey, Ph.D., director of medical physics at TCSC expects the time savings Elekta VMAT, a new that targets tumors high doses of ..

Evaluating cost-effectiveness of genetic screening to guide - HULIQ (pres bi13750183 Evaluating cost-effectiveness of genetic screening to guide HULIQ (press release), NC - 5 hours ago The authors determined that genetic testing for HLA-B*5701 cost-effective, but only abacavir-based as effective among those testing ..

'HIV+, TB patients deserve better treatment' - Independent Online bi13750183 'HIV+, TB patients deserve better ' Independent Online, South Africa - 3 hours ago By Hazel Memani A South African study has shown that mortality among tuberculosis and HIV co-infected patients can be reduced by 55 percent. Investigation: HIV+ patients smoke ARVs Independent Online all 5 news articles..

New Leukemia Signal Could Point Way to Better Treatment, Stanford - Marke bi13750183 ChattahBox New Leukemia Signal Could Point Way to Better , Stanford MarketWatch - Sep 17, 2008 It would be a big advantage cancer a drug were developed that could selectively kill cancer but help healthy cells grow. New Clues May Lead To Leukemia Drugs, ChattahBox Blocking Enzyme Proves Efficient Leukemia eFluxMedia Stanford Researchers Hope For New Leukemia AHN Ivanhoe - MedPage Todayall 38 news articles..

Biogen Idec Features Data on AVONEX(R) and TYSABRI(R) and - MarketWatch bi13750183 Biogen Idec Features Data on AVONEX(R) and TYSABRI(R) and MarketWatch - 5 hours ago will present new data on the company's leading multiple sclerosis (MS) franchise at the World Congress on and Research Multiple Sclerosis ..

Oxygen device helps lung treatment - The Press Association bi13750183 Oxygen device helps lung The Press Association - 56 minutes ago A breathing machine originally designed for mountain climbers has been turned a new for chronic lung disease. The closed circuit oxygen ..

Drug Combo Fights Recurrent Ovarian Cancer Cell Growth - U.S. News & World Re bi13750183 Drug Combo Fights Recurrent Ovarian Cancer Cell Growth U.S. News & World Report, DC - 2 hours ago The international Phase III study included 672 ovarian cancer patients whose disease had progressed after first-line . ..

METH TREATMENT FUNDS OKAYED - Santa Ynez Valley Journal bi13750183 METH TREATMENT FUNDS OKAYED Santa Ynez Valley Journal, ca - 1 hour ago Capps said the grant allow the county to enhance substance abuse among hard-to-treat clients and those severely addicted to highly addictive ..

Brake Pad Change - Home